DR. ARCHIBALD JAMES MIXSON, M.D.
Osteopathic Medicine at Thistlebridge Dr, Rockville, MD
License number
Maryland D0035064
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
15620 Thistlebridge Dr, Rockville, MD 20853
Phone
(410) 706-3223
Personal information
See more information about ARCHIBALD JAMES MIXSON at radaris.comName
Address
Phone
15620 Thistlebridge Dr, Rockville, MD 20853
15620 Thistlebridge Ct, Rockville, MD 20853
3210 Norbeck Rd, Silver Spring, MD 20906
7708 Baederwood Ct, Derwood, MD 20855
1 Baederwood Ct, Derwood, MD 20855
Professional information
See more information about ARCHIBALD JAMES MIXSON at trustoria.com
Highly Branched Hk Peptides As Effective Carriers Of Sirna
Highly Branched Hk Peptides As Effective Carriers Of Sirna
US Patent:
2011027, Nov 10, 2011
Filed:
Jun 6, 2010
Appl. No.:
12/794764
Inventors:
Archibald MIXSON - Rockville MD, US
International Classification:
C07K 1/113
US Classification:
530322
Abstract:
The present invention is directed to methods of transfecting cells with siRNA, by contacting a transfection complex with one or more cells, where the transfection complex includes a transport polymer and siRNA. The transport polymer may include for example, HK8b and/or structurally similar compounds. The invention is also directed to such transfection complexes, and to compositions that include such transfection complexes. The invention is further directed to methods of treating patients using the transfection complexes of the present invention.
Highly Branched Hk Peptides As Effective Carriers Of Sirna
Highly Branched Hk Peptides As Effective Carriers Of Sirna
US Patent:
2008017, Jul 17, 2008
Filed:
Nov 17, 2005
Appl. No.:
11/718342
Inventors:
Archibald Mixson - Rockville MD, US
International Classification:
A61K 31/70, C12N 5/06, A61K 35/12, A61P 43/00, C07H 21/04
US Classification:
424 9321, 435375, 536 245, 514 44
Abstract:
The present invention is directed to methods of transfecting cells with siRNA, by contacting a transfection complex with one or more cells, where the transfection complex includes a transport polymer and siRNA. The transport polymer may include for example, HK8b and/or structurally similar compounds. The invention is also directed to such transfection complexes, and to compositions that include such transfection complexes. The invention is further directed to methods of treating patients using the transfection complexes of the present invention.